Neogen Corporation — FY2024 Form 10-K Summary
Reporting period: Fiscal year ended May 31, 2024; comparisons are with the fiscal year ended May 31, 2023. This filing reports annual results, not a separate fiscal fourth-quarter summary. Unless otherwise noted, financial amounts below are in millions of U.S. dollars.
Business context
Neogen develops and markets food-safety testing products and animal-safety products and services. Its two reportable segments are Food Safety and Animal Safety. The results reflect a full year of the 3M Food Safety Division (FSD), acquired in a Reverse Morris Trust transaction that closed September 1, 2022. Food Safety generated 70.9% of FY2024 revenue; Animal Safety generated 29.1%. International customers accounted for 49.7% of revenue.
Financial results and liquidity
| Metric | FY2024 | FY2023 |
|---|---|---|
| Revenue | $924.2 | $822.4 |
| Gross profit / gross margin | $463.9 / 50.2% | $406.0 / 49.4% |
| Operating income | $58.7 | $37.5 |
| Net loss | $(9.4) | $(22.9) |
| Diluted loss per share | $(0.04) | $(0.12) |
| Adjusted EBITDA / margin (non-GAAP) | $213.2 / 23.1% | $205.4 / 25.0% |
| Cash from operating activities | $35.3 | $41.0 |
Food Safety revenue was $655.3, up 20%; management attributed $98.6 of the increase to acquisitions, including FSD, and $20.0 to business growth, partly offset by $10.1 of unfavorable currency effects. Animal Safety revenue was $268.9, down 2%, including a $5.5 decline in the business and $0.6 of unfavorable currency effects. Service revenue was $102.4, down 5%.
Gross margin improved mainly because FSD contributed a full year of higher-margin sales. Adjusted EBITDA rose $7.7, but its margin declined 1.9 percentage points, primarily reflecting higher operating expenses as the combined business was integrated. Net loss narrowed, while interest expense increased to $73.4 from $56.0, largely reflecting acquisition-related debt and higher rates.
At May 31, 2024, cash and cash equivalents were $170.6 and marketable securities were $0.3. The $150.0 revolving credit facility was undrawn. Debt principal was $900.0, plus a $2.4 finance lease; reported non-current debt net of issuance costs was $888.4. The term loan and notes mature in 2027 and 2030, respectively. The weighted-average long-term debt rate was 7.71%; approximately 33.3% of debt was at variable rates after the interest-rate swap. The company reported compliance with debt covenants.
Material changes versus FY2023
- Revenue increased 12%, substantially reflecting the full-year contribution of the acquired FSD business; excluding the first-quarter acquired product contributions, management reported modest growth in several Food Safety categories.
- Operating income increased $21.1, while sales and marketing expense rose $41.7, mainly due to FSD-related costs and distribution transition inefficiencies. Total operating expenses increased 10%.
- Operating cash flow declined $5.8. Inventory increased $55.5 to $189.3 as Neogen began stocking FSD products after exiting 3M distribution arrangements; management also cited working-capital outflows.
- Capital spending and other purchases of property, equipment, and non-current intangible assets totaled $111.4, compared with $65.8 in FY2023. Investing cash flow was a $29.3 outflow, versus a $201.0 inflow in FY2023, when marketable securities maturities were substantial.
- Receivables increased to $173.0 from $153.3; days sales outstanding rose to 61 days from 57 days for the legacy business comparison disclosed by management.
Outlook, risks and unusual items
- Management expects FY2025 capital expenditures of approximately $85, including about $55 for FSD integration and the new Lansing manufacturing facility. R&D spending is expected to be approximately 2%–4% of revenue annually. Several new or improved products are expected to become commercially available during FY2025 and FY2026. No specific revenue or earnings guidance is provided.
- Management said order-fulfillment issues and elevated backlog associated with the ERP implementation and exit from 3M transition distribution agreements had largely been resolved by fiscal year-end. Geopolitical tensions, including the Russia-Ukraine and Israel-Hamas conflicts, and their potential effects on costs and supply remain relevant into FY2025.
- Internal controls are a significant reporting risk: management and the auditor concluded internal control over financial reporting was ineffective at May 31, 2024. Remaining material weaknesses concern IT general controls (user access and change management) and period-end invoice accruals. A weakness relating to acquisition accounting review was deemed remediated. The auditor issued an adverse opinion on internal control, while giving an unqualified opinion on the financial statements.
- Goodwill was $2.136 billion, including $2.054 billion in Food Safety; no impairment was recorded. Management disclosed that an adverse 50-basis-point change in the Food Safety reporting unit’s revenue-growth or discount-rate assumption would cause estimated fair value to fall below carrying value and could result in impairment.
- Other key risks include realizing FSD integration benefits, supplier and manufacturing disruptions, competition, international and currency exposure, regulatory requirements, cybersecurity and successful later phases of the SAP ERP implementation. Debt covenants and floating-rate exposure constrain flexibility; a 75-basis-point increase in rates was estimated to reduce earnings by $2.25 million.
- Management said ordinary-course legal proceedings are not expected to materially affect results or financial position. The company recorded a $0.916 million estimated liability for long-term environmental remediation at its Wisconsin facility. FY2024 cost of revenue included $1.265 million of business-interruption insurance proceeds related to a prior-year fire.
Most important facts for investors to verify
- Whether Food Safety growth, FSD integration synergies and improved fulfillment persist, and how much growth is organic versus acquisition-related.
- Remediation progress and independent testing of the IT general-control and invoice-accrual weaknesses; monitor subsequent filings for any restatement or control-status change.
- Food Safety goodwill valuation assumptions and impairment headroom, given the disclosed sensitivity to small assumption changes and the substantial goodwill balance.
- Debt reduction, interest costs, covenant headroom and liquidity as the company funds its manufacturing build-out and integration capital spending.
- Inventory quality and turnover, receivable collections, and whether working-capital investment converts into stronger operating cash flow.